Amyloid β-peptide (42-1) (human)
Cat. No. 3391
Biological ActivityInactive control peptide for amyloid β-peptide (1-42) (Cat. No. 1428), the predominant form of amyloid β-peptide found in the brains of patients with Alzheimer's disease.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Safety Data Sheet
Xiong et al (2007) Mitochondrial respiratory inhibition and oxidative stress elevate β-secretase (BACE1) proteins and activity in vivo in the rat retina. Exp.Brain Res. 181 435. PMID: 17429617.
Boyd-Kimball et al (2005) Proteomic identification of proteins oxidized by Aβ(1-42) in synaptosomes: Implications for Alzheimer's disease. Brain Res. 1004 206. PMID: 15885219.
Walsh et al (2002) Amyloid-beta peotide is toxic to neurons in vivo via indirect mechanisms. Neurobiol.Dis. 10 20. PMID: 12079400.
If you know of a relevant reference for this product please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses Amyloid β-peptide (42-1) (human) from Tocris? If so please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: Amyloid b-peptide (42-1) (human), supplier, Inactive, control, peptide, β-Amyloid, beta-Amyloid, b-amyoid, Precursor, Protein, APP, Secretase, beta, Peptides, Amyloid, β-peptide, beta-peptide, (42-1), (human), amyloidbeta, amyloidb, amyloidβ, Tocris Bioscience, Amyloid β Peptide products
Find multiple products by catalog number
New Products in this Area
Mitochondrial protonophore uncouplerRS 1
High affinity RAD51 activator; also CRISPR enhancer6-Hydroxy-DL-DOPA
Allosteric inhibitor of RAD52; also APE1 inhibitor
November 12 - 16, 2016
San Diego, CA, USA